Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitor...
Saved in:
Main Author: | Yury Ivanovich Suntsov |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/dcc60c358f43471d88cbed7d0e3e67d5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
by: Stefan D. Anker
Published: (2019) -
Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients
by: Alina Babenko, et al.
Published: (2014) -
Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018) -
Heart failure in diabetes: From an increased risk to a treatment target
by: Eberhard Standl
Published: (2018) -
Modern basal insulins: an ongoing story or the start of a new era?
by: Ivan Ivanovich Dedov
Published: (2015)